{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:10:15Z","timestamp":1783246215571,"version":"3.54.6"},"reference-count":48,"publisher":"Pleiades Publishing Ltd","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1134\/s0006297925600565","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:56:44Z","timestamp":1756483004000},"page":"1140-1152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nephroprotective Effects of Silymarin: A Systematic Review and Meta-Analysis"],"prefix":"10.1134","volume":"90","author":[{"given":"Negin","family":"Frounchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Mahmoodpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Sina","family":"Zakavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Eyvazova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Yagubova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Ardalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilgiz","family":"Gareev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozal","family":"Beylerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Roumiantsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"2899_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-020-1016-x","volume":"22","author":"Z. Wang","year":"2020","unstructured":"Wang, Z., do Carmo, J. M., da Silva, A. A., Fu, Y., and Hall, J. E. (2020) Mechanisms of synergistic interactions of diabetes and hypertension in chronic kidney disease: role of mitochondrial dysfunction and ER stress, Curr. Hypertens. Rep., 22, 15, \nhttps:\/\/doi.org\/10.1007\/s11906-020-1016-x.","journal-title":"Curr. Hypertens. Rep."},{"key":"2899_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116109","volume":"22","author":"E. Kwiatkowska","year":"2021","unstructured":"Kwiatkowska, E., Doma\u0144ski, L., Dziedziejko, V., Kajdy, A., Stefa\u0144ska, K., and Kwiatkowski, S. (2021) The mechanism of drug nephrotoxicity and the methods for preventing kidney damage, Int. J. Mol. Sci., 22, 6109, \nhttps:\/\/doi.org\/10.3390\/ijms22116109.","journal-title":"Int. J. Mol. Sci."},{"key":"2899_CR3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/s0140-6736(19)32977-0","volume":"395","author":"P. Cockwell","year":"2020","unstructured":"Cockwell, P., and Fisher, L. A. (2020) The global burden of chronic kidney disease, Lancet, 395, 662-664, \nhttps:\/\/doi.org\/10.1016\/s0140-6736(19)32977-0.","journal-title":"Lancet"},{"key":"2899_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16130-8","volume":"23","author":"S. Zhang","year":"2023","unstructured":"Zhang, S., Ren, H. F., Du, R. X., Sun, W. L., Fu, M. L., and Zhang, X. C. (2023) Global, regional, and national burden of kidney dysfunction from 1990 to 2019: a systematic analysis from the global burden of disease study 2019, BMC Public Health, 23, 1218, \nhttps:\/\/doi.org\/10.1186\/s12889-023-16130-8.","journal-title":"BMC Public Health"},{"key":"2899_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"C. P. Kovesdy","year":"2022","unstructured":"Kovesdy, C. P. (2022) Epidemiology of chronic kidney disease: an update 2022, Kidney Int. Suppl., 12, 7-11, \nhttps:\/\/doi.org\/10.1016\/j.kisu.2021.11.003.","journal-title":"Kidney Int. Suppl."},{"key":"2899_CR6","first-page":"1583","volume":"41","author":"Q. W. Shi","year":"2010","unstructured":"Shi, Q. W., Li, L., Huo, C.-H., Zhang, M., and Wang, Y.-F. (2010) Study on natural medicinal chemistry and new drug development, Chinese Trad. Herb. Drugs, 41, 1583-1589.","journal-title":"Chinese Trad. Herb. Drugs"},{"key":"2899_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153890","volume":"96","author":"P. K. Teja","year":"2022","unstructured":"Teja, P. K., Mithiya, J., Kate, A. S., Bairwa, K., and Chauthe, S. K. (2022) Herbal nanomedicines: recent advancements, challenges, opportunities and regulatory overview, Phytomedicine, 96, 153890, \nhttps:\/\/doi.org\/10.1016\/j.phymed.2021.153890.","journal-title":"Phytomedicine"},{"key":"2899_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.30699\/jambs.31.144.73","volume":"31","author":"F. Mahmoodpoor","year":"2023","unstructured":"Mahmoodpoor, F., Hosseini, S. H., Ahmadian, E., Ardalan, M., Kamali, K., Zununi Vahed, S., Sardari, S., and Khavasi, N. (2023) The histopathological evaluation of the effects of capparis spinosa seed hydroalcoholic extract on cisplatin-induced-nephrotoxicity in rats, J.\u00a0Adv. Med. Biomed. Res., 31, 73-79, \nhttps:\/\/doi.org\/10.30699\/jambs.31.144.73.","journal-title":"J.\u00a0Adv. Med. Biomed. Res."},{"key":"2899_CR9","doi-asserted-by":"publisher","unstructured":"Corchete, P. (2008) Silybum marianum (L.) Gaertn: the source of silymarin, in Bioactive Molecules and Medicinal Plants, Springer, pp.\u00a0123-148, \nhttps:\/\/doi.org\/10.1007\/978-3-540-74603-4_6.","DOI":"10.1007\/978-3-540-74603-4_6"},{"key":"2899_CR10","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/ptr.3207","volume":"24","author":"L. Abenavoli","year":"2010","unstructured":"Abenavoli, L., Capasso, R., Milic, N., and Capasso, F. (2010) Milk thistle in liver diseases: past, present, future, Phytother. Res., 24, 1423-1432, \nhttps:\/\/doi.org\/10.1002\/ptr.3207.","journal-title":"Phytother. Res."},{"key":"2899_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/vms3.641","volume":"8","author":"R. Khazaei","year":"2022","unstructured":"Khazaei, R., Seidavi, A., and Bouyeh, M. (2022) A review on the mechanisms of the effect of silymarin in milk thistle (Silybum marianum) on some laboratory animals, Vet. Med. Sci., 8, 289-301, \nhttps:\/\/doi.org\/10.1002\/vms3.641.","journal-title":"Vet. Med. Sci."},{"key":"2899_CR12","doi-asserted-by":"publisher","DOI":"10.15414\/jmbfs.2020.9.4.836-843","volume":"9","author":"V. Valkov\u00e1","year":"2020","unstructured":"Valkov\u00e1, V., \u010e\u00faranov\u00e1, H., Bil\u010d\u00edkov\u00e1, J., and Hab\u00e1n, M. (2020) Milk thistle (Silybum marianum): a valuable medicinal plant with several therapeutic purposes, J.\u00a0Microbiol. Biotechnol. Food Sci., 9, 836, \nhttps:\/\/doi.org\/10.15414\/jmbfs.2020.9.4.836-843.","journal-title":"J.\u00a0Microbiol. Biotechnol. Food Sci."},{"key":"2899_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27165327","volume":"27","author":"K. Wadhwa","year":"2022","unstructured":"Wadhwa, K., Pahwa, R., Kumar, M., Kumar, S., Sharma, P. C., Singh, G., Verma, R., Mittal, V., Singh, I., Kaushik, D., and Jeandet, P. (2022) Mechanistic insights into the pharmacological significance of silymarin, Molecules, 27, 5327, \nhttps:\/\/doi.org\/10.3390\/molecules27165327.","journal-title":"Molecules"},{"key":"2899_CR14","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2165\/00003495-200161140-00003","volume":"61","author":"R. Saller","year":"2001","unstructured":"Saller, R., Meier, R., and Brignoli, R. (2001) The use of silymarin in the treatment of liver diseases, Drugs, 61, 2035-2063, \nhttps:\/\/doi.org\/10.2165\/00003495-200161140-00003.","journal-title":"Drugs"},{"key":"2899_CR15","first-page":"239","volume":"16","author":"S. Javed","year":"2011","unstructured":"Javed, S., Kohli, K., and Ali, M. (2011) Reassessing bioavailability of silymarin, Alternat. Med. Rev., 16, 239-249.","journal-title":"Alternat. Med. Rev."},{"key":"2899_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.ED000142","volume":"10","author":"M. Cumpston","year":"2019","unstructured":"Cumpston, M., Li, T., Page, M. J., Chandler, J., Welch, V. A., Higgins, J. P., and Thomas, J. (2019) Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook Systematic Reviews of Interventions, Cochrane Database Syst. Rev., 10, ED000142, \nhttps:\/\/doi.org\/10.1002\/14651858.ED000142.","journal-title":"Cochrane Database Syst. Rev."},{"key":"2899_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"J. P. Higgins","year":"2011","unstructured":"Higgins, J. P., Altman, D. G., G\u00f8tzsche, P. C., J\u00fcni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., and Sterne, J. A. (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, 343, d5928, \nhttps:\/\/doi.org\/10.1136\/bmj.d5928.","journal-title":"BMJ"},{"key":"2899_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-30","volume":"14","author":"N. Takeshima","year":"2014","unstructured":"Takeshima, N., Sozu, T., Tajika, A., Ogawa, Y., Hayasaka, Y., and Furukawa, T. A. (2014) Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? BMC Med. Res. Methodol., 14, 1-7, \nhttps:\/\/doi.org\/10.1186\/1471-2288-14-30.","journal-title":"BMC Med. Res. Methodol."},{"key":"2899_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S. Duval","year":"2000","unstructured":"Duval, S., and Tweedie, R. (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis, Biometrics, 56, 455-463, \nhttps:\/\/doi.org\/10.1111\/j.0006-341X.2000.00455.x.","journal-title":"Biometrics"},{"key":"2899_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M. Egger","year":"1997","unstructured":"Egger, M., Smith, G. D., Schneider, M., and Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629-634, \nhttps:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"key":"2899_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2147\/ijgm.S141111","volume":"10","author":"S. Trakulsrichai","year":"2017","unstructured":"Trakulsrichai, S., Sriapha, C., Tongpoo, A., Udomsubpayakul, U., Wongvisavakorn, S., Srisuma, S., and Wananukul, W. (2017) Clinical characteristics and outcome of toxicity from Amanita mushroom poisoning, Int. J. Gen. Med., 10, 395-400, \nhttps:\/\/doi.org\/10.2147\/ijgm.S141111.","journal-title":"Int. J. Gen. Med."},{"key":"2899_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.34172\/PS.2020.33","volume":"26","author":"M. Mahi-Birjand","year":"2020","unstructured":"Mahi-Birjand, M., Karimzadeh, I., Zarban, A., Abdollahpour-Alitappeh, M., Saadatjoo, S. A., and Ziaee, M. (2020) Protective effects of silymarin on gentamicin-induced nephrotoxicity in infectious patients: a randomized double blinded placebo-controlled clinical trial, Pharmaceut. Sci., 26, 287-295, \nhttps:\/\/doi.org\/10.34172\/PS.2020.33.","journal-title":"Pharmaceut. Sci."},{"key":"2899_CR23","doi-asserted-by":"publisher","DOI":"10.4103\/2008-7802.174762","volume":"7","author":"Z. Sedighifard","year":"2016","unstructured":"Sedighifard, Z., Roghani, F., Bidram, P., Harandi, S. A., and Molavi, S. (2016) Silymarin for the prevention of contrast-induced nephropathy: a placebo-controlled clinical trial, Int.\u00a0J. Prevent. Med., 7, 23, \nhttps:\/\/doi.org\/10.4103\/2008-7802.174762.","journal-title":"Int.\u00a0J. Prevent. Med."},{"key":"2899_CR24","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2016.043","volume":"8","author":"A. A. Hagag","year":"2016","unstructured":"Hagag, A. A., Elgamsy, M. A., El-Asy, H. M., and Mabrouk, M. M. (2016) Protective role of silymarin on hepatic and renal toxicity induced by MTX based chemotherapy in children with acute lymphoblastic leukemia, Mediterr. J. Hematol. Infect. Dis., 8, e2016043, \nhttps:\/\/doi.org\/10.4084\/mjhid.2016.043.","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"2899_CR25","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/ptr.5345","volume":"29","author":"F. Shahbazi","year":"2015","unstructured":"Shahbazi, F., Sadighi, S., Dashti-Khavidaki, S., Shahi, F., Mirzania, M., Abdollahi, A., and Ghahremani, M. H. (2015) Effect of silymarin administration on cisplatin nephrotoxicity: report from a pilot, randomized, double-blinded, placebo-controlled clinical trial, Phytother. Res., 29, 1046-1053, \nhttps:\/\/doi.org\/10.1002\/ptr.5345.","journal-title":"Phytother. Res."},{"key":"2899_CR26","doi-asserted-by":"publisher","first-page":"OC11","DOI":"10.7860\/jcdr\/2015\/12776.5789","volume":"9","author":"A. Momeni","year":"2015","unstructured":"Momeni, A., Hajigholami, A., Geshnizjani, S., and Kheiri, S. (2015) Effect of silymarin in the prevention of cisplatin nephrotoxicity, a clinical trial study, J.\u00a0Clin. Diagn. Res., 9, OC11-OC13, \nhttps:\/\/doi.org\/10.7860\/jcdr\/2015\/12776.5789.","journal-title":"J.\u00a0Clin. Diagn. Res."},{"key":"2899_CR27","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s11255-017-1697-5","volume":"49","author":"L. Voroneanu","year":"2017","unstructured":"Voroneanu, L., Siriopol, D., Dumea, R., Badarau, S., Kanbay, M., Afsar, B., Gavrilovici, C., and Covic, A. (2017) Addition of silymarin to renin-angiotensin system blockers in normotensive patients with type 2 diabetes mellitus and proteinuria: a prospective randomized trial, Int. Urol. Nephrol., 49, 2195-2204, \nhttps:\/\/doi.org\/10.1007\/s11255-017-1697-5.","journal-title":"Int. Urol. Nephrol."},{"key":"2899_CR28","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1053\/j.ajkd.2012.06.005","volume":"60","author":"M. K. Fallahzadeh","year":"2012","unstructured":"Fallahzadeh, M. K., Dormanesh, B., Sagheb, M. M., Roozbeh, J., Vessal, G., Pakfetrat, M., Daneshbod, Y., Kamali-Sarvestani, E., and Lankarani, K. B. (2012) Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial, Am. J. Kidney Dis., 60, 896-903, \nhttps:\/\/doi.org\/10.1053\/j.ajkd.2012.06.005.","journal-title":"Am. J. Kidney Dis."},{"key":"2899_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/0886022x.2010.541579","volume":"33","author":"J. Roozbeh","year":"2011","unstructured":"Roozbeh, J., Shahriyari, B., Akmali, M., Vessal, G., Pakfetrat, M., Raees Jalali, G. A., Afshariani, R., Hasheminasab, M., and Ghahramani, N. (2011) Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis, Renal Failure, 33, 118-123, \nhttps:\/\/doi.org\/10.3109\/0886022x.2010.541579.","journal-title":"Renal Failure"},{"key":"2899_CR30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/hdi.12413","volume":"20","author":"O. Firuzi","year":"2016","unstructured":"Firuzi, O., Khajehrezaei, S., Ezzatzadegan, S., Nejati, M., Jahanshahi, K. A., and Roozbeh, J. (2016) Effects of silymarin on biochemical and oxidative stress markers in end-stage renal disease patients undergoing peritoneal dialysis, Hemodial. Int., 20, 558-563, \nhttps:\/\/doi.org\/10.1111\/hdi.12413.","journal-title":"Hemodial. Int."},{"key":"2899_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.18502\/jimc.v4i3.7220","volume":"4","author":"S. Shabani","year":"2021","unstructured":"Shabani, S., Baghbahadorani, F. K., Jazaeri, F., Ganji, F., Mortazavi, N. S., and Mahmoudnia, L. (2021) The effects of silymarin and N-acetylcysteine on liver and kidney dysfunction in subjects with severe pre-eclampsia, J.\u00a0Iran. Med. Council, 4, 173-182, \nhttps:\/\/doi.org\/10.18502\/jimc.v4i3.7220.","journal-title":"J.\u00a0Iran. Med. Council"},{"key":"2899_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-022-03803-x","volume":"22","author":"F. Terzi","year":"2022","unstructured":"Terzi, F., and Ciftci, M. K. (2022) Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity, BMC Complement. Med. Ther., 22, 331, \nhttps:\/\/doi.org\/10.1186\/s12906-022-03803-x.","journal-title":"BMC Complement. Med. Ther."},{"key":"2899_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091772","volume":"12","author":"N. Piko","year":"2023","unstructured":"Piko, N., Bevc, S., Hojs, R., and Ekart, R. (2023) The role of oxidative stress in kidney injury, Antioxidants, 12, 1772, \nhttps:\/\/doi.org\/10.3390\/antiox12091772.","journal-title":"Antioxidants"},{"key":"2899_CR34","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00467-018-4005-4","volume":"34","author":"K. Daenen","year":"2019","unstructured":"Daenen, K., Andries, A., Mekahli, D., Van Schepdael, A., Jouret, F., and Bammens, B. (2019) Oxidative stress in chronic kidney disease, Pediatr. Nephrol., 34, 975-991, \nhttps:\/\/doi.org\/10.1007\/s00467-018-4005-4.","journal-title":"Pediatr. Nephrol."},{"key":"2899_CR35","doi-asserted-by":"publisher","DOI":"10.1088\/1742-6596\/1853\/1\/012038","volume":"1853","author":"K. S. Abod","year":"2021","unstructured":"Abod, K. S., Mohammed, M. T., and Taay, Y. M. (2021) Evaluation of total oxidant status and antioxidant capacity in sera of acute-and chronic-renal failure patients, J.\u00a0Phys. Conf. Ser., 1853, 012038, \nhttps:\/\/doi.org\/10.1088\/1742-6596\/1853\/1\/012038.","journal-title":"J.\u00a0Phys. Conf. Ser."},{"key":"2899_CR36","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8046","volume":"7","author":"A. M. Tomsa","year":"2019","unstructured":"Tomsa, A. M., Alexa, A. L., Junie, M. L., Rachisan, A. L., and Ciumarnean, L. (2019) Oxidative stress as a potential target in acute kidney injury, PeerJ, 7, e8046, \nhttps:\/\/doi.org\/10.7717\/peerj.8046.","journal-title":"PeerJ"},{"key":"2899_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1755-5922.2010.00218.x","volume":"30","author":"A. A. Elmarakby","year":"2012","unstructured":"Elmarakby, A. A., and Sullivan, J. C. (2012) Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy, Cardiovasc. Ther., 30, 49-59, \nhttps:\/\/doi.org\/10.1111\/j.1755-5922.2010.00218.x.","journal-title":"Cardiovasc. Ther."},{"key":"2899_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/antiox4010204","volume":"4","author":"P. F. Surai","year":"2015","unstructured":"Surai, P. F. (2015) Silymarin as a natural antioxidant: an overview of the current evidence and perspectives, Antioxidants, 4, 204-247, \nhttps:\/\/doi.org\/10.3390\/antiox4010204.","journal-title":"Antioxidants"},{"key":"2899_CR39","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1177\/1934578X1300801236","volume":"8","author":"N. Mili\u0107","year":"2013","unstructured":"Mili\u0107, N., Milosevi\u0107, N., Suvajdzi\u0107, L., Zarkov, M., and Abenavoli, L. (2013) New therapeutic potentials of milk thistle (Silybum marianum), Nat. Prod. Commun., 8, 1801-1810, \nhttps:\/\/doi.org\/10.1177\/1934578X1300801236.","journal-title":"Nat. Prod. Commun."},{"key":"2899_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108240","volume":"237","author":"Y. Fu","year":"2022","unstructured":"Fu, Y., Xiang, Y., Li, H., Chen, A., and Dong, Z. (2022) Inflammation in kidney repair: Mechanism and therapeutic potential, Pharmacol. Ther., 237, 108240, \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2022.108240.","journal-title":"Pharmacol. Ther."},{"key":"2899_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020458","volume":"9","author":"J. Donate-Correa","year":"2020","unstructured":"Donate-Correa, J., Luis-Rodr\u00edguez, D., Mart\u00edn-N\u00fa\u00f1ez, E., Tagua, V. G., Hern\u00e1ndez-Carballo, C., Ferri, C., Rodr\u00edguez-Rodr\u00edguez, A. E., Mora-Fern\u00e1ndez, C., and Navarro-Gonz\u00e1lez, J. F. (2020) Inflammatory targets in diabetic nephropathy, J. Clin. Med., 9, 458, \nhttps:\/\/doi.org\/10.3390\/jcm9020458.","journal-title":"J. Clin. Med."},{"key":"2899_CR42","first-page":"136","volume":"52","author":"V. Ivanov","year":"2020","unstructured":"Ivanov, V., Slavova, V., Georgieva, D., Petrova-Tacheva, V., and Tolekova, A. (2020) Use of silymarin for reducing nephrotoxicity caused by medicaments, Bulgar. Chem. Commun., 52, 136-141.","journal-title":"Bulgar. Chem. Commun."},{"key":"2899_CR43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.15547\/tjs.2021.02.011","volume":"19","author":"V. Ivanov","year":"2021","unstructured":"Ivanov, V., Slavova, V., Georgieva, D., Petrova-Tacheva, V., and Tolekova, A. (2021) Beneficial effects of silymarin against nephrotoxicity caused by some chemicals, Trakia J. Sci., 19, 178-184, \nhttps:\/\/doi.org\/10.15547\/tjs.2021.02.011.","journal-title":"Trakia J. Sci."},{"key":"2899_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.18433\/j3f88s","volume":"15","author":"S. Dashti-Khavidaki","year":"2012","unstructured":"Dashti-Khavidaki, S., Shahbazi, F., Khalili, H., and Lessan-Pezeshki, M. (2012) Potential renoprotective effects of silymarin against nephrotoxic drugs: a review of literature, J.\u00a0Pharm. Pharmaceut. Sci., 15, 112-123, \nhttps:\/\/doi.org\/10.18433\/j3f88s.","journal-title":"J.\u00a0Pharm. Pharmaceut. Sci."},{"key":"2899_CR45","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3906\/biy-1506-75","volume":"40","author":"M. Cengiz","year":"2016","unstructured":"Cengiz, M., Ayhanci, A., Kutlu, H. M., and Musmul, A. (2016) Potential therapeutic effects of silymarin and silymarin-loaded solid lipidnanoparticles on experimental kidney damage in BALB\/c mice: biochemical and histopathological evaluation, Turkish J. Biol., 40, 807-814, \nhttps:\/\/doi.org\/10.3906\/biy-1506-75.","journal-title":"Turkish J. Biol."},{"key":"2899_CR46","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1002\/ptr.8173","volume":"38","author":"S. Mohammadi","year":"2024","unstructured":"Mohammadi, S., Ashtary-Larky, D., Asbaghi, O., Farrokhi, V., Jadidi, Y., Mofidi, F., Mohammadian, M., and Afrisham, R. (2024) Effects of silymarin supplementation on liver and kidney functions: a systematic review and dose-response meta-analysis, Phytother. Res., 38, 2572-2593, \nhttps:\/\/doi.org\/10.1002\/ptr.8173.","journal-title":"Phytother. Res."},{"key":"2899_CR47","first-page":"429","volume":"53","author":"S. Gharahveysi","year":"2019","unstructured":"Gharahveysi, S. (2019) Milk thistle protective effect on liver and kidney of broiler chickens, Agricult. Nat. Res., 53, 429-432.","journal-title":"Agricult. Nat. Res."},{"key":"2899_CR48","first-page":"91","volume":"28","author":"M. Shilaey","year":"2015","unstructured":"Shilaey, M., and Hosseini, S. M. (2015) Effect of use purslane and milk thistle medicinal plants in the diet on enzymes activity, blood metabolites and egg characteristics of laying hens, Anim. Sci.\u00a0J., 28, 91-102.","journal-title":"Anim. Sci.\u00a0J."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297925600565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297925600565","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297925600565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:23:25Z","timestamp":1773620605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297925600565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2899"],"URL":"https:\/\/doi.org\/10.1134\/s0006297925600565","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      This work does not contain any studies involving human or animal subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no\u00a0conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}